# Nigella Sativa in COVID-19

> **NCT04401202** · PHASE2 · COMPLETED · sponsor: **King Abdulaziz University** · enrollment: 183 (actual)

## Conditions studied

- COVID-19
- SARS-CoV-2

## Interventions

- **DIETARY_SUPPLEMENT:** Nigella sativa oil

## Key facts

- **NCT ID:** NCT04401202
- **Lead sponsor:** King Abdulaziz University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-05-21
- **Primary completion:** 2020-12-31
- **Final completion:** 2020-12-31
- **Target enrollment:** 183 (ACTUAL)
- **Last updated:** 2021-05-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04401202

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04401202, "Nigella Sativa in COVID-19". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04401202. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*